Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Macapinlac

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
First impressions. A 21-yr-old woman with adenocarcinoma of the pelvis. What is the radiopharmaceutical? What are the findings?H Yeung, H Macapinlac
Clinical Nuclear Medicine|August 31, 1999
Increased F-18 FDG uptake in the stomachR F Nunez, H W Yeung, H Macapinlac
American Heart Journal|August 1, 1992
Myocardial entrapment by lymphoma: a cause of reversible segmental left ventricular dysfunctionN Roistacher, M Preminger, H Macapinlac, et al.
European Journal of Nuclear Medicine|January 1, 1994
Tracer imaging in lung cancerH M Abdel-Dayem, A Scott, H Macapinlac, et al.
Revista Espanola De Medicina Nuclear|February 1, 2002
[FGD PET in a patient with pseudofractures from osteomalacia]A Sánchez Salmón, R Núñez, H Yeung, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 25, 2006
A retrospective analysis of the impact of 18F-FDG PET scans on clinical management of 133 breast cancer patientsJ F Y Santiago, M Gonen, H Yeung, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Accuracy of FDG-PET in Gastric Cancer. Preliminary ExperienceH W.D. Yeung, H Macapinlac, M Karpeh, et al.
Nuclear Medicine and Biology|July 1, 1994
Current status of radioimmunodetectionS M Larson, C Divgi, A Scott, et al.
Thyroid : Official Journal of the American Thyroid Association|March 16, 2000
Inhibition of metabolic activity in papillary thyroid carcinoma by a somatostatin analogueR J Robbins, R H Hill, W Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myelomaA M el-Shirbiny, H Yeung, M Imbriaco, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
First impressions. A 21-yr-old woman with adenocarcinoma of the pelvis. What is the radiopharmaceutical? What are the findings?H Yeung, H Macapinlac
Clinical Nuclear Medicine|August 31, 1999
Increased F-18 FDG uptake in the stomachR F Nunez, H W Yeung, H Macapinlac
American Heart Journal|August 1, 1992
Myocardial entrapment by lymphoma: a cause of reversible segmental left ventricular dysfunctionN Roistacher, M Preminger, H Macapinlac, et al.
European Journal of Nuclear Medicine|January 1, 1994
Tracer imaging in lung cancerH M Abdel-Dayem, A Scott, H Macapinlac, et al.
Revista Espanola De Medicina Nuclear|February 1, 2002
[FGD PET in a patient with pseudofractures from osteomalacia]A Sánchez Salmón, R Núñez, H Yeung, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 25, 2006
A retrospective analysis of the impact of 18F-FDG PET scans on clinical management of 133 breast cancer patientsJ F Y Santiago, M Gonen, H Yeung, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Accuracy of FDG-PET in Gastric Cancer. Preliminary ExperienceH W.D. Yeung, H Macapinlac, M Karpeh, et al.
Nuclear Medicine and Biology|July 1, 1994
Current status of radioimmunodetectionS M Larson, C Divgi, A Scott, et al.
Thyroid : Official Journal of the American Thyroid Association|March 16, 2000
Inhibition of metabolic activity in papillary thyroid carcinoma by a somatostatin analogueR J Robbins, R H Hill, W Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myelomaA M el-Shirbiny, H Yeung, M Imbriaco, et al.
Pageof 3